Automation index

How much of a Gastroenterologist’s job can AI already do?

A colonoscopy report comes earlier. Putting the scope in and not perforating do not.

This percentage does not predict how many people will lose their jobs.

Task comparison

IS WORK OVER?

22%

AI can already do 22% of this job.

#352 / 633

Gastroenterologist

Task weights are our estimates based on O*NET frequency data, not time shares published by O*NET.

The time saving for each task is estimated separately.

Task	Share	AI	Points
Read endoscopies, labs and the transit study. Estimate No public source provides a precise figure. This is our estimate.	16%	48%	+7.7
Colonoscopy, gastroscopy and ERCP. Estimate No public source provides a precise figure. This is our estimate.	22%	10%	+2.2
IBD, hepatitis and reflux plans. Estimate No public source provides a precise figure. This is our estimate.	16%	28%	+4.5
Abdomen clinic, occult blood and the fear of cancer. Estimate No public source provides a precise figure. This is our estimate.	16%	22%	+3.5
GI emergencies and the bleed that does not stop. Estimate No public source provides a precise figure. This is our estimate.	16%	18%	+2.9
Consent, perforation and signing the procedure. Estimate No public source provides a precise figure. This is our estimate.	14%	12%	+1.7
Total	100%		22%

Modelled workweek: 100% · Public evidence: 0% · Estimate: 100% · Confidence: Low

IS WORK OVER?

23%

#311 / 633

Radiation oncologist

Task weights are our estimates based on O*NET frequency data, not time shares published by O*NET.

The time saving for each task is estimated separately.

Task	Share	AI	Points
Contouring, fractions and the dose plan. Estimate No public source provides a precise figure. This is our estimate.	16%	48%	+7.7
Clinic, the tumour and what can be irradiated. Estimate No public source provides a precise figure. This is our estimate.	18%	18%	+3.2
Simulation, immobilisation and the machine day. Estimate No public source provides a precise figure. This is our estimate.	16%	22%	+3.5
Side effects, pauses and the patient who cannot take it. Estimate No public source provides a precise figure. This is our estimate.	16%	28%	+4.5
Board, the surgeon and the medical oncologist. Estimate No public source provides a precise figure. This is our estimate.	18%	14%	+2.5
Signing the plan and the dose that does not erase. Estimate No public source provides a precise figure. This is our estimate.	16%	12%	+1.9
Total	100%		23%

Modelled workweek: 100% · Public evidence: 0% · Estimate: 100% · Confidence: Low